Inside information News Regulated Oxurion signs a letter of intent for the acquisition of an international CRO EN NL FR March 19, 2026
Inside information News Regulated Oxurion confirms continuation of discussions regarding its proposed acquisition of a French CRO EN NL FR February 27, 2026
General Inside information News Regulated Axiodis CRO accelerates its sales and marketing strategy to support ambitious growth driven by Oxurion EN NL FR February 16, 2026
General Inside information News Regulated Oxurion announces the temporary suspension of the financing programme dedicated to investments in digital assets and crypto-assets EN NL FR January 19, 2026
Inside information News Regulated Oxurion secures a binding €30 million financing facility dedicated to investments in digital and crypto-assets EN NL FR December 1, 2025
Inside information News Regulated Oxurion ends discussions regarding previously announced preclinical transaction and continues integration of a strategic clinical partner EN NL FR November 3, 2025
Inside information News Regulated Oxurion signs letter of intent for the contemplated acquisition of a CRO with strong complementarity to Axiodis EN NL FR October 13, 2025
Inside information News Regulated Oxurion provides an update related to its investment strategy in digital assets EN NL FR October 9, 2025
General Inside information News Regulated Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials EN NL FR September 16, 2025
Inside information News Regulated Oxurion confirms progress in negotiations related to its treasury diversification strategy; closing of the transaction expected before September 25, 2025 EN NL FR September 1, 2025
Inside information News Regulated Oxurion Ends R&D Program in Geographic Atrophy and Refocuses on New CRO Activities EN NL FR August 7, 2025
Inside information News Regulated Oxurion announces it obtained an improved indicative €30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets EN NL FR August 4, 2025
General Inside information News Regulated Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform EN NL FR August 4, 2025
Inside information News Regulated Oxurion plans to launch a treasury diversification strategy into digital assets under a €10M indicative agreement with its main investor EN NL FR July 22, 2025
Inside information News Regulated Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025 EN NL FR Annex July 17, 2025
Inside information News Regulated Oxurion Announces the Fulfilment of the Second Condition Precedent in the Acquisition of Axiodis EN NL FR July 10, 2025
Inside information News Regulated Oxurion moves forward with the planned acquisition of Axiodis EN NL FR June 12, 2025
Inside information Regulated Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO EN NL FR May 16, 2025
Inside information News Regulated Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025 EN NL FR April 25, 2025